Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disruption of RNA metabolism and its impact on protein homeostasis. | Philos Trans R Soc Lond B Biol Sci | 2026 | 42817623 | PubTator, text mining | PubMed |
| Antisense Oligonucleotide-Mediated Degradation of Toxic RNA in Myotonic Dystrophy Type 1. | Methods Mol Biol | 2026 | 42814302 | PubTator, text mining | PubMed |
| MBNL depletion drives stem cell fusion and immature myonuclear states in myotonic dystrophy type 1. | Nat Commun | 2026 | 42693134 | PubTator, text mining | PubMed |
| CRISPR/dCas9-mediated tuning of DMPK transcription reveals a quantitative relationship between toxic repeat RNA expression and MBNL1 activity in myotonic dystrophy. | Hum Mol Genet | 2026 | 42627995 | PubTator, text mining | PubMed |
| An Ultrastructural and Proteomic Analysis in DM1 Young Adults' Myoblasts: Stressed RER and Mitochondrial Dysfunction Involvement. | J Cell Mol Med | 2026 | 42601835 | PubTator, text mining | PubMed |
| Prenatal manifestations and perinatal outcomes in congenital myotonic dystrophy: clinical patterns and diagnostic implications. | Case Rep Perinat Med | 2026 | 42577704 | PubTator, text mining | PubMed |
| Natural History of Adult-Onset Myotonic Dystrophy Type 1: Longitudinal Changes in Radiologic, Clinical, and Patient-Reported Outcomes. | Neurology | 2026 | 42525903 | PubTator, text mining | PubMed |
| Genotype-phenotype relationship in a cohort of 131 Chinese patients with myotonic dystrophy type 1. | BMC Neurol | 2026 | 42471599 | PubTator, text mining | PubMed |
| Atypical Phenotype of Myotonic Dystrophy Type 1 with Variant Repeats at the Age of Diagnosis. | Biology (Basel) | 2026 | 42450630 | PubTator, text mining | PubMed |
| Aberrant neuronal differentiation and splicing defects in Congenital Myotonic Dystrophy (DM1) iPSC models. | bioRxiv | 2026 | 42427665 | PubTator, text mining | PubMed |
| Tissue-specific CTG•CAG expansion rate and disease severity are modified by DNA repair genes expression levels in myotonic dystrophy type 1 patients. | DNA Repair (Amst) | 2026 | 42419013 | PubTator, text mining | PubMed |
| Current Topics of Progressive Cardiac Conduction Disease. | J Arrhythm | 2026 | 42368294 | PubTator, text mining | PubMed |
| A new era for myotonic dystrophy: Improved delivery of a DMPK-targeted oligonucleotide modulates muscle transcriptomes and function. | Mol Ther | 2026 | 42341747 | PubTator, text mining | PubMed |
| Generation of isogenic rescue iPSC lines by targeted CTG-repeat excision for myotonic dystrophy type 1. | Stem Cell Res | 2026 | 42341615 | PubTator, text mining | PubMed |
| Spectrum of potentially lethal cardiac conditions presenting with fetal sinus bradycardia: a report on 34 cases. | Ultrasound Obstet Gynecol | 2026 | 42333052 | PubTator, text mining | PubMed |
| Neurofilament light chain reflects motor impairment in myotonic dystrophy type 1. | Front Neurol | 2026 | 42273033 | PubTator, text mining | PubMed |
| Optical mapping reveals a higher level of large-scale structural variants in a family with paternally transmitted myotonic dystrophy and independent Parkinson's disease. | J Pathol | 2026 | 42261605 | PubTator, text mining | PubMed |
| Antisense-mediated gene therapy targeting DMPK restores cardiac ion channel function and electrical stability in myotonic dystrophy type 1. | Heart Rhythm | 2026 | 42248312 | PubTator, text mining | PubMed |
| A pilot study on the application of Oxford Nanopore PromethION sequencing with adaptive sampling for DMPK repeat expansion sizing in myotonic dystrophy type 1. | Clin Chim Acta | 2026 | 42214742 | PubTator, text mining | PubMed |
| Computational Short Tandem Repeat Genotyping Reveals Clinically Relevant Expansions in a Large Turkish Neurodegeneration Disease Cohort. | Int J Mol Sci | 2026 | 42196324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers